Ad
IPHA - Innate Pharma S A Stock Trading
About | Innate Pharma S.A. (NYSE:IPHA)
Quote | Innate Pharma S.A. (NYSE:IPHA)
| Last: | $ |
|---|---|
| Change Percent: | 1.60% |
| Open: | $7.75 |
| Close: | $7.60 |
| High: | $7.75 |
| Low: | $7.57 |
| Volume: | 5,364 |
| Last Trade Date Time: | 02/12/2020 04:44:19 pm |
News | Innate Pharma S.A. (NYSE:IPHA)
-
Efficacy results, analyzed according to updated lymph node involvement classification, confirm clinical activity and favorable safety profile of lacutamab in advanced Mycosis Fungoides Updated global ORR of 42.9% in heavily pretreated KIR3DL2-expressing patients with Mycosis F...
-
2023-09-14 11:54:09 ET Innate Pharma S.A. (IPHA) Q2 2023 Earnings Conference Call September 14, 2023, 08:00 AM ET Company Participants Henry Wheeler - VP, IR & Communication Mondher Mahjoubi - CEO Joyson Karakunnel - Interim Chief Medical Officer Yannis M...
Message Board Posts | Innate Pharma S.A. (NYSE:IPHA)
| Subject | By | Source | When |
|---|---|---|---|
| MomentumIts trading | lakoob2 | investorshub | 07/07/2023 2:27:48 PM |
| Do we have a winner?Turn around time? | TheFinalCD | investorshub | 07/07/2023 5:16:31 AM |
| $IPHA Good news recently, we should start to see this one move | tw0122 | investorshub | 07/05/2023 12:18:57 PM |
| $IPHA short squeeze | crudeoil24 | investorshub | 07/05/2023 7:50:06 AM |
| $IPHA where is the squeeze? | makinezmoney | investorshub | 07/03/2023 7:30:10 PM |
Innate Pharma S.A. Company Name:
IPHA Stock Symbol:
NYSE Market:
Ad
-
Efficacy results, analyzed according to updated lymph node involvement classification, confirm clinical activity and favorable safety profile of lacutamab in advanced Mycosis Fungoides Updated global ORR of 42.9% in heavily pretreated KIR3DL2-expressing patients with Mycosis F...
-
Phase 1/2 dose escalation safety and preliminary efficacy of ANKET ® NK cell engager, SAR'579/IPH6101, developed by Sanofi, showed it was well tolerated with observed clinical benefit in patients with R/R AML (ASCO 2023 annual meeting), FDA Fast Track Designation awarded Excl...
-
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that members of its senior management team are scheduled to participate in upcoming investor conferences, detailed below. In addition, the Company will hold a c...